Innovating Neurodivergent Biomarkers
- AI-driven
outcomes
We are revolutionizing early detection! The field of
neuroscience is primed for innovations in detecting developmental differences. mHealthcare is
introducing the world's first commercial-grade neurodivergent screening platform tailored
explicitly for infants.
Explore
now
Contact
